Sham-procedure

OTHER2 trials

Sponsors

Laboratoires Thea

Conditions

Deaf BlindEye DiseasesEye Diseases, HereditaryEye Disorders CongenitalRetinal DiseaseRetinitis PigmentosaUsher Syndrome Type 2Vision Disorders

Phase 2

Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius)

TerminatedNCT05158296

Laboratoires TheaDeaf Blind, Eye Diseases, Eye Diseases, Hereditary +5

Start: 2021-12-08End: 2022-10-12Updated: 2024-07-12

Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste)

TerminatedNCT05176717

Laboratoires TheaDeaf Blind, Eye Diseases, Eye Diseases, Hereditary +5

Start: 2021-12-15End: 2022-08-02Updated: 2024-08-07